About Arctava

Arctava’s Strong Foundation

Arctava is a Canadian Contract Biopharmaceutical Organization founded by leading experts in the pharmaceutical industry, bringing a wealth of knowledge and expertise to you.

Our Team

  • Headshot of Melanie Milburn

    Melanie Milburn

    CEO | BOARD DIRECTOR | LEADER & MENTOR

    With over 25 years of experience in the Canadian pharmaceutical industry, I have held roles at many companies including Sanofi and Pfizer and, most recently, I served as Canadian General Manager at Elvium Life Sciences/Purdue Pharma Canada. Currently, I am the CEO of Arctava and serve on the Board of Directors at Oak Valley Health and at Nucleus Independent Living. I am a passionate advocate for innovation, collaboration, and patient-centered care, recognized for building high-performing teams, mentoring future leaders, and driving meaningful impact across the healthcare system.

  • Headshot of Mike Cloutier

    Mike Cloutier

    CHAIR OF THE BOARD | PARTNER, INTERNATIONAL BUSINESS DEVELOPMENT 

    With more than four decades of leadership experience across Canadian life sciences, I have proudly led major organizations including AstraZeneca Canada, Pharmacia Canada, Searle Canada, InterMune Canada, PTC Therapeutics and the Canadian Diabetes Association with a hope that we would do our part in the system to help improve the lives of Canadian patients and caregivers. When I founded Accelera Canada our work was to help emerging biopharma companies navigate market entry, commercialization and access in Canada and that will again be my goal in this new role. As Chair of the Board at Arctava, I look to leverage years of Board and Advisory roles to bring governance discipline, leadership perspective and an extensive industry network to support biopharmaceutical companies working to succeed in Canada.

  • Headshot of Charlie Pirraglia

    Charlie Pirraglia

    CHIEF COMMERCIAL OFFICER | PARTNER

    With more than 25 years of experience in pharmaceutical consulting, commercialization, sales and marketing, I have helped life sciences organizations define corporate, portfolio and launch strategies for the Canadian market and translate those strategies into successful execution. I have held sales and marketing roles at various medical device and pharmaceutical companies including J&J, Hoffmann-La Roche and Sanofi-Aventis. I founded Podium Strategic Partners and was a Partner at Accelera Canada; both companies were later acquired by Everana, where I continued as General Manager. Throughout my career, I have supported the development of more than 100 corporate, portfolio and commercial launch plans across a broad range of therapeutic areas. At Arctava, I bring senior commercial experience, launch discipline and a deep understanding of the Canadian market to our clients, enabling them to navigate complexity, make informed decisions and achieve commercial success in Canada.

  • Headshot of Ryan Clarke

    Ryan Clarke, LL.B.

    CHIEF LEGAL & ADVOCACY OFFICER | PARTNER 

    With more than three decades at the intersection of law, government, public affairs, stakeholder engagement and healthcare advocacy, I have built and led advocacy strategies that help organizations engage decision-makers and mobilize support for meaningful change. After my experience at GlaxoSmithKline, I founded Advocacy Solutions, later joined Accelera Canada as a Senior Partner, and then served as Senior Vice-President, Advocacy and PR at Eversana. At Arctava, I bring a legal perspective, policy competence and stakeholder advocacy expertise to support strategic, credible, and commercially relevant engagement in Canada.

  • Headshot of Jodan Ratz

    Jodan Ratz, PhD

    STRATEGIC MEDICAL AFFAIRS LEADER | REGULATORY STRATEGY | CLINICAL RESEARCH | BUSINESS DEVELOPMENT

    With over 25 years of experience in the pharmaceutical industry and clinical research, I bring deep leadership experience across medical strategy, regulatory affairs, clinical trials, and complex healthcare decision-making, with a strong track record of helping organizations navigate pivotal moments where scientific rigor, regulatory judgment, and strategic clarity must come together. Let me provide your team with senior-led support when facing high-stakes decisions in rapidly evolving environments. An integrated medical, regulatory, and commercial approach that is practical, decisive, and execution-focused will allow you to move faster, manage risk, and make better-informed decisions.

  • Headshot of Christian Roy

    Christian Roy

    LIFE SCIENCES EXECUTIVE AND ENTREPRENEUR I TRUSTED ADVISOR - BOARD MEMBER

    With 30 years of experience in healthcare, working with both large multinational corporations and as an entrepreneur, I now serve as a consultant for businesses in the healthcare sector and various other industries. I hold the positions of co-chair and senior advisor at BridgeBright Inc. and serve as an Independent Director and member of the Compliance & Compensation Committee on the Board of HLS Therapeutics. Additionally, I am a Director of the Operating Board of the Montreal Institute of Palliative Care and a Director of the Foundation Board of John Abbott College.

  • Headshot of Ryan Brown

    Ryan Brown

    COMMERCIAL LEADER | GROWTH DRIVER ACROSS Rx and CONSUMER HEALTH | EXPERT IN BRAND STRATEGY

    With over 20 years of experience in both the Canadian and US pharmaceutical industry, I bring extensive experience across biopharmaceutical and consumer health commercial management, paired with a strong background in consulting services. My depth of expertise includes brand strategy, commercialization, and translating insight into clear, actionable plans that drive growth. I have worked across complex portfolios and therapeutic areas, helping teams sharpen strategy and execute with confidence. I welcome opportunities to collaborate with your team to simplify complexity, refine strategy, and turn bold ideas into action.

Ready to Connect?

Arctava is your Contract Biopharmaceutical Organization with all of the solutions you need to bring your product to market in Canada.

Let’s discuss your next steps.